
The Artificial Intelligence Fundus Aided Diagnosis Software is the engine for the screening, diagnosis and treatment of ophthalmic diseases.
The global market for Artificial Intelligence Fundus Aided Diagnosis Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The artificial intelligence fundus-assisted diagnosis software market is an emerging market in the medical field, covering the field of using advanced artificial intelligence technology to assist ophthalmologists in fundus image analysis and disease diagnosis. These software can quickly and accurately detect and identify fundus diseases, such as diabetic retinopathy, glaucoma and macular degeneration, etc., providing doctors with critical diagnostic support and treatment recommendations. The emergence of artificial intelligence fundus-assisted diagnosis software has greatly improved the efficiency and accuracy of ophthalmology diagnosis, and is expected to promote the modernization and popularization of ophthalmology medical care on a global scale, while also promoting the application and development of artificial intelligence technology in the medical field. The market competition is becoming increasingly fierce, and various software vendors are constantly optimizing their algorithms and performance to meet the needs of medical institutions and professional doctors for high-quality fundus diagnostic tools. The market is expected to continue to expand and have a positive impact on ophthalmic care.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Fundus Aided Diagnosis Software, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Artificial Intelligence Fundus Aided Diagnosis Software by region & country, by Type, and by Application.
The Artificial Intelligence Fundus Aided Diagnosis Software market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Fundus Aided Diagnosis Software.
Market Segmentation
By Company
WeDoctor
Vistel
Sibionics
Airdoc
Baidu
Aiforia
Topcon Healthcare
Alpha-Brick
DeepMind
Phoebus
°ä²â²ú±ð°ù​â¶Ä‹s¾±²µ³ó³Ù
Vuno
RetInSight
Acer Medical
Thirona
Ophtai
Segment by Type:
Single Disease
Multiple Diseases
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artificial Intelligence Fundus Aided Diagnosis Software manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Artificial Intelligence Fundus Aided Diagnosis Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Artificial Intelligence Fundus Aided Diagnosis Software in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Artificial Intelligence Fundus Aided Diagnosis Software Product Introduction
1.2 Global Artificial Intelligence Fundus Aided Diagnosis Software Market Size Forecast
1.3 Artificial Intelligence Fundus Aided Diagnosis Software Market Trends & Drivers
1.3.1 Artificial Intelligence Fundus Aided Diagnosis Software Industry Trends
1.3.2 Artificial Intelligence Fundus Aided Diagnosis Software Market Drivers & Opportunity
1.3.3 Artificial Intelligence Fundus Aided Diagnosis Software Market Challenges
1.3.4 Artificial Intelligence Fundus Aided Diagnosis Software Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Intelligence Fundus Aided Diagnosis Software Players Revenue Ranking (2023)
2.2 Global Artificial Intelligence Fundus Aided Diagnosis Software Revenue by Company (2019-2024)
2.3 Key Companies Artificial Intelligence Fundus Aided Diagnosis Software Manufacturing Base Distribution and Headquarters
2.4 Key Companies Artificial Intelligence Fundus Aided Diagnosis Software Product Offered
2.5 Key Companies Time to Begin Mass Production of Artificial Intelligence Fundus Aided Diagnosis Software
2.6 Artificial Intelligence Fundus Aided Diagnosis Software Market Competitive Analysis
2.6.1 Artificial Intelligence Fundus Aided Diagnosis Software Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Artificial Intelligence Fundus Aided Diagnosis Software Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Fundus Aided Diagnosis Software as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Single Disease
3.1.2 Multiple Diseases
3.2 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Type
3.2.1 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, by Type (2019-2030)
3.2.3 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Application
4.2.1 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, by Application (2019-2030)
4.2.3 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Region
5.1.1 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Region (2019-2024)
5.1.3 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Region (2025-2030)
5.1.4 Global Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
5.2.2 North America Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
5.3.2 Europe Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
5.4.2 Asia Pacific Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
5.5.2 South America Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
5.6.2 Middle East & Africa Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Intelligence Fundus Aided Diagnosis Software Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Artificial Intelligence Fundus Aided Diagnosis Software Sales Value
6.3 United States
6.3.1 United States Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
6.3.2 United States Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
6.4.2 Europe Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
6.5.2 China Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Type (%), 2023 VS 2030
6.5.3 China Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
6.6.2 Japan Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
6.7.2 South Korea Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
6.8.2 Southeast Asia Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Artificial Intelligence Fundus Aided Diagnosis Software Sales Value, 2019-2030
6.9.2 India Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Type (%), 2023 VS 2030
6.9.3 India Artificial Intelligence Fundus Aided Diagnosis Software Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 WeDoctor
7.1.1 WeDoctor Profile
7.1.2 WeDoctor Main Business
7.1.3 WeDoctor Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.1.4 WeDoctor Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.1.5 WeDoctor Recent Developments
7.2 Vistel
7.2.1 Vistel Profile
7.2.2 Vistel Main Business
7.2.3 Vistel Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.2.4 Vistel Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.2.5 Vistel Recent Developments
7.3 Sibionics
7.3.1 Sibionics Profile
7.3.2 Sibionics Main Business
7.3.3 Sibionics Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.3.4 Sibionics Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.3.5 Airdoc Recent Developments
7.4 Airdoc
7.4.1 Airdoc Profile
7.4.2 Airdoc Main Business
7.4.3 Airdoc Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.4.4 Airdoc Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.4.5 Airdoc Recent Developments
7.5 Baidu
7.5.1 Baidu Profile
7.5.2 Baidu Main Business
7.5.3 Baidu Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.5.4 Baidu Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.5.5 Baidu Recent Developments
7.6 Aiforia
7.6.1 Aiforia Profile
7.6.2 Aiforia Main Business
7.6.3 Aiforia Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.6.4 Aiforia Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.6.5 Aiforia Recent Developments
7.7 Topcon Healthcare
7.7.1 Topcon Healthcare Profile
7.7.2 Topcon Healthcare Main Business
7.7.3 Topcon Healthcare Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.7.4 Topcon Healthcare Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.7.5 Topcon Healthcare Recent Developments
7.8 Alpha-Brick
7.8.1 Alpha-Brick Profile
7.8.2 Alpha-Brick Main Business
7.8.3 Alpha-Brick Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.8.4 Alpha-Brick Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.8.5 Alpha-Brick Recent Developments
7.9 DeepMind
7.9.1 DeepMind Profile
7.9.2 DeepMind Main Business
7.9.3 DeepMind Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.9.4 DeepMind Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.9.5 DeepMind Recent Developments
7.10 Phoebus
7.10.1 Phoebus Profile
7.10.2 Phoebus Main Business
7.10.3 Phoebus Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.10.4 Phoebus Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.10.5 Phoebus Recent Developments
7.11 °ä²â²ú±ð°ù​â¶Ä‹s¾±²µ³ó³Ù
7.11.1 °ä²â²ú±ð°ù​â¶Ä‹s¾±²µ³ó³Ù Profile
7.11.2 °ä²â²ú±ð°ù​â¶Ä‹s¾±²µ³ó³Ù Main Business
7.11.3 °ä²â²ú±ð°ù​â¶Ä‹s¾±²µ³ó³Ù Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.11.4 °ä²â²ú±ð°ù​â¶Ä‹s¾±²µ³ó³Ù Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.11.5 °ä²â²ú±ð°ù​â¶Ä‹s¾±²µ³ó³Ù Recent Developments
7.12 Vuno
7.12.1 Vuno Profile
7.12.2 Vuno Main Business
7.12.3 Vuno Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.12.4 Vuno Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.12.5 Vuno Recent Developments
7.13 RetInSight
7.13.1 RetInSight Profile
7.13.2 RetInSight Main Business
7.13.3 RetInSight Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.13.4 RetInSight Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.13.5 RetInSight Recent Developments
7.14 Acer Medical
7.14.1 Acer Medical Profile
7.14.2 Acer Medical Main Business
7.14.3 Acer Medical Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.14.4 Acer Medical Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.14.5 Acer Medical Recent Developments
7.15 Thirona
7.15.1 Thirona Profile
7.15.2 Thirona Main Business
7.15.3 Thirona Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.15.4 Thirona Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.15.5 Thirona Recent Developments
7.16 Ophtai
7.16.1 Ophtai Profile
7.16.2 Ophtai Main Business
7.16.3 Ophtai Artificial Intelligence Fundus Aided Diagnosis Software Products, Services and Solutions
7.16.4 Ophtai Artificial Intelligence Fundus Aided Diagnosis Software Revenue (US$ Million) & (2019-2024)
7.16.5 Ophtai Recent Developments
8 Industry Chain Analysis
8.1 Artificial Intelligence Fundus Aided Diagnosis Software Industrial Chain
8.2 Artificial Intelligence Fundus Aided Diagnosis Software Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Intelligence Fundus Aided Diagnosis Software Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Intelligence Fundus Aided Diagnosis Software Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
WeDoctor
Vistel
Sibionics
Airdoc
Baidu
Aiforia
Topcon Healthcare
Alpha-Brick
DeepMind
Phoebus
°ä²â²ú±ð°ù​â¶Ä‹s¾±²µ³ó³Ù
Vuno
RetInSight
Acer Medical
Thirona
Ophtai
Ìý
Ìý
*If Applicable.
